Atomoxetine; Vortioxetine/Strong 2D6 Inhibitors Interactions

This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.

Medical warning:

Serious. These medicines may interact and cause very harmful effects. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.

How the interaction occurs:

Bupropion, dacomitinib, fluoxetine, paroxetine, quinidine or terbinafine(taken by mouth) may slow down how quickly your liver processes atomoxetine or vortioxetine.

What might happen:

The amount of atomoxetine or vortioxetine in your blood may increase and cause more side effects than normal. Atomoxetine side effects may include increased blood pressure, faster heart rate, irritability, nausea, vomiting, or decreased appetite. Vortioxetine side effects may include headache, nausea, vomiting, dizziness, or abnormal dreams.

What you should do about this interaction:

Make sure your healthcare professionals (e.g. doctor or pharmacist) know that you are taking these medicines together. Your doctor may want to adjust the dose of your atomoxetine or vortioxetine. Let your doctor know if you have any side effects from your medicine.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.

  • 1.US Food and Drug Administration (FDA). Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers. Available at: https://www.fda.gov/drugs/drug-interactions-labeling/drug-development-and- drug-interactions-table-substrates-inhibitors-and-inducers. Updated 11/14/2017.
  • 2.Trintellix (vortioxetine) US prescribing information. Takeda Pharmaceuticals America, Inc. November, 2020.
  • 3.Chen G, Lee R, Hojer AM, Buchbjerg JK, Serenko M, Zhao Z. Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant. Clin Drug Investig 2013 Oct;33(10):727-36.
  • 4.This information is based on an extract from the Certara Drug Interaction Database (DIDB) Platform, Copyright Certara 1999-2023..
  • 5.Strattera (atomoxetine hydrochloride) US prescribing information. Eli Lilly and Company January, 2022.
  • 6.Pexeva (paroxetine mesylate) US prescribing information. Noven Therapeutics, LLC September, 2021.
  • 7.Belle DJ, Ernest CS, Sauer JM, Smith BP, Thomasson HR, Witcher JW. Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics. J Clin Pharmacol 2002 Nov;42(11):1219-27.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.